New Zealand has one of the highest rates of melanoma in the world but lags in funding novel drugs that […]
Continue readingkeytruda
Pharmac confirms funding for melanoma drug – In the News
Drug-buying agency Pharmac officially announced funding for the melanoma treatment Keytruda on Tuesday. It followed a provisional decision in June […]
Continue readingPHARMAC needs funding boost – Dr Francis Hunter
Writing on Stuff.co.nz* the University of Auckland’s Dr Francis Hunter outlines the situation PHARMAC and the Government face over the […]
Continue readingPush for Keytruda funding – Expert reaction
Public pressure is growing for the Government to fund the melanoma drug Keytruda, listed as ‘low priority’ by drug funding […]
Continue readingPHARMAC not to fund melanoma drug – In the News
PHARMAC’s decision not to fund melanoma treatment pembrolizumab – marketed as Keytruda – has been widely covered in the media. Public […]
Continue reading